DD210709A1 - Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b - Google Patents

Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b

Info

Publication number
DD210709A1
DD210709A1 DD83258052A DD25805283A DD210709A1 DD 210709 A1 DD210709 A1 DD 210709A1 DD 83258052 A DD83258052 A DD 83258052A DD 25805283 A DD25805283 A DD 25805283A DD 210709 A1 DD210709 A1 DD 210709A1
Authority
DD
German Democratic Republic
Prior art keywords
antibiotic
factors
preparing
formula
pharmaceutically acceptable
Prior art date
Application number
DD83258052A
Other languages
German (de)
English (en)
Inventor
Marvin M Hoehn
Gary G Marconi
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD210709A1 publication Critical patent/DD210709A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K9/00Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365Nocardia
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DD83258052A 1982-12-20 1983-12-16 Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b DD210709A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45088082A 1982-12-20 1982-12-20

Publications (1)

Publication Number Publication Date
DD210709A1 true DD210709A1 (de) 1984-06-20

Family

ID=23789893

Family Applications (1)

Application Number Title Priority Date Filing Date
DD83258052A DD210709A1 (de) 1982-12-20 1983-12-16 Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b

Country Status (24)

Country Link
EP (1) EP0112184B1 (fr)
JP (2) JPS59118798A (fr)
KR (1) KR860001497B1 (fr)
AT (1) ATE42571T1 (fr)
AU (1) AU563466B2 (fr)
CA (1) CA1214413A (fr)
DD (1) DD210709A1 (fr)
DE (1) DE3379735D1 (fr)
DK (1) DK167688B1 (fr)
EG (1) EG16163A (fr)
ES (1) ES528197A0 (fr)
FI (1) FI834594A (fr)
GB (1) GB2132207B (fr)
GR (1) GR78784B (fr)
HK (1) HK72088A (fr)
HU (1) HU192971B (fr)
IE (1) IE56382B1 (fr)
IL (1) IL70441A (fr)
NZ (1) NZ206592A (fr)
PH (1) PH20198A (fr)
PT (1) PT77810A (fr)
RO (1) RO87735A2 (fr)
SU (1) SU1194285A3 (fr)
ZA (1) ZA839269B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572178D1 (en) * 1984-04-16 1989-09-14 Lilly Co Eli Improvements in and relating to antibiotics m43a, m43b, m43c and m43d
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
RU2633511C1 (ru) * 2016-06-29 2017-10-12 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Штамм Amycolatopsis orientalis - продуцент антибиотика диметилванкомицина и способ получения антибиотика

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1
US4322343A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Pseudo-aglycone of actaplanin

Also Published As

Publication number Publication date
KR860001497B1 (ko) 1986-09-27
PH20198A (en) 1986-10-16
ES8504935A1 (es) 1985-05-01
EP0112184B1 (fr) 1989-04-26
GB2132207B (en) 1986-06-04
GB2132207A (en) 1984-07-04
JPH0771479B2 (ja) 1995-08-02
DK578083D0 (da) 1983-12-15
EP0112184A3 (en) 1985-06-19
RO87735B1 (ro) 1985-10-01
DK578083A (da) 1984-06-21
HK72088A (en) 1988-09-16
JPS59118798A (ja) 1984-07-09
ATE42571T1 (de) 1989-05-15
AU563466B2 (en) 1987-07-09
FI834594A0 (fi) 1983-12-14
IE832990L (en) 1984-06-20
JPH05168466A (ja) 1993-07-02
PT77810A (en) 1984-01-01
EG16163A (en) 1989-01-30
IE56382B1 (en) 1991-07-17
RO87735A2 (fr) 1985-10-31
IL70441A0 (en) 1984-03-30
DK167688B1 (da) 1993-12-06
FI834594A (fi) 1984-06-21
KR840007437A (ko) 1984-12-07
NZ206592A (en) 1987-02-20
DE3379735D1 (en) 1989-06-01
ZA839269B (en) 1985-07-31
AU2242683A (en) 1984-06-28
JPH0430400B2 (fr) 1992-05-21
CA1214413A (fr) 1986-11-25
ES528197A0 (es) 1985-05-01
GR78784B (fr) 1984-10-02
SU1194285A3 (ru) 1985-11-23
EP0112184A2 (fr) 1984-06-27
GB8333668D0 (en) 1984-01-25
IL70441A (en) 1986-11-30
HU192971B (en) 1987-08-28

Similar Documents

Publication Publication Date Title
PT78777B (en) Process for preparing leucine derivatives and of pharmaceutical compositions containing the same
ATE155469T1 (de) Verfahren zur herstellung von cephemderivaten
DE69106003D1 (de) Verfahren und zwischenprodukte zur herstellung von azabicyclo[2.2.2]octan-3-iminen.
DD210709A1 (de) Verfahren zur herstellung des antibiotikums a51568 mit den faktoren a und b
ATE54148T1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
JPS55111463A (en) Beta-lactam compound and its preparation
HUT58097A (en) Process for producing 3,7-diazobicyclo(3,3.1)nonane compounds and pharmaceutical compositions comprising same
ATE111092T1 (de) Antibiotikum a80915 und verfahren zu seiner herstellung.
PT78325B (en) Process for preparing novel macrolides ptl-448
JPS5671092A (en) Optical active cephalosporin analogous derivative
DE3360601D1 (en) Macrolide antibiotics from streptomyces
ES2060962T3 (es) Antibioticos glicopeptidicos.
JPS5511541A (en) Novel antibiotics and their preparation